HIF1α inhibition by dual targeting of CDK4/6 and HSP90 reduces cancer cell viability including Rb-deficient cells
S. Zhao, L. Zhou, D. Dicker, A. Lev, S. Zhang, W. El-Deiry
This study shows that combining CDK4/6 and HSP90 inhibitors reduces HIF1 expression and cancer cell viability, including in Rb-deficient cells.
bioRxiv · Oct 20, 2020 · PreprintCancer Biology